German device industry welcomes DRG (Diagnosis Related Groups) innovation decision
This article was originally published in Clinica
Executive Summary
The German industry association for medical devices (BVMed) last week welcomed recommendations from the upper house of parliament, the Bundesrat, to amend a clause in the existing DRG (Diagnosis Related Groups) law. In an open letter to the federal and regional health ministers, as well as members of the lower house's (Bundestag) health committee, BVMed said the amendment would ensure that innovative technology is speedily and adequately integrated into the new system.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.